UDSv4 and Digital Voice

UDSv4 Digital Voice

About Digital Voice

Introduction

Uniform Data Set Version 4 (UDSv4) will give centers the option to collect digital audio recordings of the cognition section of the UDS study. NACC and the Clinical Task Force (CTF) Technology Workgroup are collaborating to support Alzheimer’s Disease Researcher Center (ADRC) adoption of digital voice as part of the UDSv4 rollout.

More information and resources will be provided to ADRCs in the coming months detailing best practices, protocols, and more.

Why digital voice?

The implementation of digitally recording participant responses to neuropsychological tests is a cost-effective way to detect early changes in cognition. As our cognitive capabilities shift, we express them through vocal responses in subtle ways, such as changing word choices or sentence structures because of word finding problems, pausing, hesitating, and shifting as memory, attention, and executive functions are compromised.

Currently, there are no gold standards in methods for analyzing voice recordings in relation to cognition. However, just as with blood-based biomarkers, there is a growing, albeit still limited, set of literature suggesting that analysis of digital voice recordings as a method for differentiating those with and without cognitive impairment is promising.

Benefits of digital voice

  • A non-diluting resource: Digital data can be repurposed for different purposes as algorithms and analysis techniques improve.
  • Minimal participant burden: NP tests are already being conducted; digital voice collection allows for scientific enablement at no additional burden to participants.
  • Low cost and inclusive: Penetration of recording devices allows for easy, low-cost collection of voice data that can be done in the person’s native language.
  • Novel analytics: Natural Language Processing (NLP) and other advanced machine-learning methods offer opportunities to explore acoustic and semantic features in novel forms.
  • Quality control (QC): Digitally recorded voice tasks can act as a QC tool to determine natural drift in standardization in any longitudinal study.

Supporting Digital Voice Data Collection - A Collaboration with the Clinical Task Force Technology Workgroup

NACC and the Clinical Task Force (CTF) Technology Workgroup are collaborating to support ADRC adoption of digital data modalities, starting with digital voice as part of the UDSv4 rollout! This workgroup's goal is to expand and enrich AD/ADRD data collection with less burden on participants and clinical staff. It aims to identify and develop guidelines for high impact digital data modalities that will be collected, integrated, and harmonized from across the ADRC Program and shared with researchers via the Data Front Door.

The CTF Technology Workgroup consists of the CTF Technology Workgroup Parent and the following three sub-committees:

New Non-UDS Digital Instruments:

Co-leads: Jeff Kaye MD (OHSU), Kate Papp, PhD (Mass Gen/Harvard), Jason Hassenstab, PhD (Washington University of St. Louis)

This committee will cover a myriad of different assessments and/or technologies, from radar to robots! Focusing on identifying high value non-UDS assessments that can be adopted by ADRC’s with minimal burden for participants and clinical staff and encourage involvement of the diverse sub-populations or cohorts across the ADRC ecosystem.

In-Clinic UDS Digital Instruments:

Co-leads: Teresa Gomez-Isla, MD (Mass Gen/Havard), Kate Possin, PhD (UCSF), Hiroko Dodge, PhD (Mass Gen/Harvard)

This committee will guide and support the implementation of audio recording of traditional paper-based UDS measures. We will review and propose in-clinic digital tests that acquire clinically meaningful data with minimal participant and staff burden for incorporation into the UDS.

Virtual Standard UDS:

Co-leads: Sudeshna Das, PhD (Mass Gen/Harvard), Zach Beattie, PhD (OHSU), Melissa Lamar, PhD (Rush ADRC)

This committee will establish guidelines and best practices for conducting virtual Unified Data Set (UDS) assessments. We will define the minimal virtual UDS dataset, provide recommendations for the virtual administration process, evaluate the equivalency of virtual and in-person evaluations, and address logistical considerations.

Events and Training

Webinar: UDS 4.0 Digital Voice Training Workshop

Date: Wednesday, June 26

NACC and the CTF Technology Workgroup hosted a training workshop focused on digital voice data collection. This workshop provided guidance on the consent process, recording procedures, and data storage for digital voice data. Leaders in the digital voice field presented research findings emphasizing the scientific importance and potential of digital voice data!

View slides here

Agenda

  • 10min - Introduction
  • 30min - Importance of Digital Voice + Q&A
  • 20min - Consent & IRB + Q&A
  • 25min - Digital Voice Data Collection + Q&A
  • 25min - Flexibility in Data Collection Protocol Adherence + Q&A
  • 10min - Closing

Our Speakers

Rhoda Au, PhD, MBA

Boston University

Professor of Anatomy and Neurobiology, Director of Neuropsychology for the Framingham Heart Study

Brad Dickerson, MD

MGB Alzheimer’s Disease Research Center, Harvard Medical School

Professor of Neurology, Leader of the Neuroimaging Core

Sudeshna Das, PhD

MGB Alzheimer’s Disease Research Center, Harvard Medical School

Associate Professor of Neurology, Leader of the Data Core

Jeffrey Kaye, PhD

Oregon Health and Science University

Director of ORCATECH and Professor of Neurology at OHSU School of Medicine

Cody Karjadi, MS

Boston University

Research Applications Developer Team Manager for the Framingham Heart Study

Melissa Lamar, PhD

Rush Alzheimer’s Disease Center and the Department of Psychiatry and Behavioral Sciences

Professor and Clinical Neuropsychologist

Nina Silverberg, PhD

NIA

ADRC Program Director

FAQs

  • What are the benefits of digital biomarkers to my ADRC?

    There are many practical benefits to adding voice recording to your ADRC, they include:

    • Acting as a QC tool to determine natural drift in standardization in any longitudinal study
    • Providing an easy, low-cost collection of data that can be done in a participant’s preferred language
    • Allowing additional scientific enablement at no additional participant burden
    • Increasing opportunities to explore acoustic and semantic features in novel forms
  • What are the benefits of digital biomarkers to participants?

    While direct participant benefit may be low at the outset, over time features of voice data may be able to:

    • Provide early indicators of cognitive impairment in preclinical or prodromal Alzheimer’s dementia
    • Help track disease progression and predict conversion to dementia
  • What are the benefits of digital biomarkers to science?

    Features of voice data are already showing promise in:

    • Serving as a dementia screening tool to detect those at risk for dementia
    • Indicating the effectiveness of clinical trials
    • Associating with CSF biomarkers of disease
  • How do I obtain local IRB approval?

    Please work with your local IRB to obtain regulatory approval for collecting digital voice data. You can reference this IRB protocol and consent language document for helpful tips and suggestions.

    PLEASE NOTE: NACC will not share any raw voice recordings until robust voice de-identification standards have been determined by NACC, NIA, ADRCs, and the CTF Technology Workgroup. NACC will provide additional guidance on data submission and sharing as this process is further defined.

  • Can I use any recorder to capture voice data for the UDSv4?

    While many devices will record voice data, NACC has certain requirements for recording UDSv4 voice data:

    • Zoom H4N recorders are preferred
    • Limited background noise
    • At the beginning of the recording state staff ID, participant ID, study visit date and number, and what is being recorded
  • Not all recorders are encrypted which may pose a significant risk should it be lost/misplaced if it contains PHI. Does this concern mean that only the more expensive, encrypted recorders should be used?

    This will be up to your local institution and ADRC. Your institution may want to adopt best practices such as;

    • Immediately upon the visit/recording&aposs termination, upload the file to a secure cloud server and delete it from the recording device.
    • If you are capturing digital voice on an iPhone there are ways to encrypt files using that device.

    There is no ‘one size fits all’ approach; however, each method will have its own issues and concerns with relation to privacy and security.

  • Do I need to process the voice data at my ADRC?

    While all ADRCs are encouraged to keep voice files for their own use, all voice data will be uploaded to NACC

    • Use NACC naming conventions: NACCID_DATE_TESTNAME
    • Store in WAV format whenever possible
    • Enter meta-data of the test in UDSv4 dVoice form (under development)
  • How do I submit digital voice data to NACC?

    NACC will be providing ADRC’s with a digital voice data submission option via the ADRC Portals hosted on NACC’s Data Platform. Learn more about the ADRC Portals.

    PLEASE NOTE: NACC will not share any raw voice recordings until robust voice de-identification standards have been determined by NACC, NIA, ADRCs, and the CTF Technology Workgroup. NACC will provide additional guidance on data submission and sharing as this process is further defined.

    At this time NACC is encouraging ADRCs to record and store digital voice data at their ADRC locally.

  • What is the UDSv4 dVoice form?

    This is a form that is under development that will accompany any voice data uploaded; it includes but is not limited to the following data variables:

    • VISIT DATE
    • NACC VISIT NUMBER
    • COGNITIVE TEST
    • TIME STAMPS (if more than 1 cogtest present in recording)
    • INTERVIEWER INITIALS
    • MASK (whether interviewer and/or participant had a mask)
    • VISIT LOCATION/SETTING
    • MICROPHONE LOCATION
    • DEVICE MANUFACTURER
    • DEVICE MODEL
    • NUMBER OF RECORDING SUBJECTS
  • How do you separate multiple speakers’ voices to focus on the participant’s voice?

    Sometimes it might be good to analyze ‘conversations’ however, automated methods are increasingly available and efficient in ‘cleaning’ vocal recordings down to a single speaker of interest.

  • What is the process for scrubbing an audio file to remove PHI? Who is handling that task?

    De-identification tools are in process for voice masking and PII splicing; however, NACC will not share any vocal data until such de-identification processes are validated and complete on all vocal recordings. Given there are multiple levels of de-identification, exploration of all levels is underway. The most important is to de-identify the voice prints themselves; estimated voice masking technology deliverables may be as early as 2025 with at least some level of PHI removal.

  • Is there a standard file type (WAV vs MP3) and bit-rate, bit depth minimums?

    Depending upon the recording equipment and/or platforms available to you, there are compromises that will need to be made (e.g., Zoom does not save to .wav formats), however, it should not prohibit you from collecting voice recordings should you wish.

    Recommended settings for digital voice recordings:

    • Uncompressed audio formats (e.g., WAV) are highly preferable.

      Sampling rate: 16KHz at a minimum (48KHz is recommended)

      Bit depth: 16-bit at a minimum (32-bit is recommended)

    • Compressed audio formats (e.g., MP3) are still accepted

      Sampling rate: must be 256kbps bit rate or higher

    • Please see the Digital Voice Data Collection Manual for recommended devices and device settings.

    Google has speech to text tool with their own recommendations which can be found here.

  • Will there be measures taken to protect the neuropsychological recordings? Neuropsychologists are advised to prevent the release of stimulus materials, test procedures, etc. of neuropsychological data. Having these things recorded allows for the potential release of this information. In addition to the NACC Battery, some sites may include copyright protected measures in their site-specific battery. What steps can be taken to protect the collection of that specific copyright materials? Can we opt out of recording those measures?

    There is no “one size fits all” when it comes to determining what can be shared and in what form. NACC is working to come up with an appropriate governance structure that ensures participant privacy and confidentiality protection. Similarly to other clinical processes, each site is encouraged to share what is feasible, and NACC will respect any agreed upon limitations to what can be shared with researchers to ensure that proprietary or copyright information is protected.